Login
$KZIA
$5.60 +$0.00 (0.0%) After hours

Company Executives

Officer In this role Source
John Friend
Chief Executive Officer
Title from the Form 3/A dated Mar 18, 2026
Not stated
James E. Levine
Chief Financial Officer
Title from the Form 4 dated Jun 19, 2026
Not stated
Sudha Rao
Chief Scientific Officer
Title from the Form 4 dated Jun 19, 2026
Not stated
Jeffrey Bonacorda
Vice President, Finance and Controller
Not stated
Elissa Hansen
Company Secretary
Since 2024
2 years
David Cain
Director, CMC
Title from the Form 3 dated Mar 18, 2026
Not stated
Jeremy Simpson
Program Director
Title from the Form 3 dated Mar 18, 2026
Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
3
serving now
Independent
3 of 3
stated in the proxy
Average tenure
5.3 years
from year joined
Director On board Independent Committees Source
Steven Coffey
2012
13 years
Independent
Audit, Risk and Governance Committee
Ebru Davidson
2023
2 years
Independent
Audit, Risk and Governance Committee · Chair
Robert Apple
2024
1 year
Independent
Audit, Risk and Governance Committee

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. KAZIA THERAPEUTICS LTD has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support